Europe Clinical Laboratory Services Market- Industry Trends and Forecast to 2030

TABLE OF CONTENTS

1 INTRODUCTION 8

• 1.1 OBJECTIVES OF THE STUDY 8
• 1.2 MARKET DEFINITION 8
• 1.3 OVERVIEW OF THE EUROPE CLINICAL LABORATORY SERVICES MARKET 8
• 1.4 LIMITATIONS 10
• 1.5 MARKETS COVERED 10

2 MARKET SEGMENTATION 12

• 2.1 MARKETS COVERED 12
• 2.2 GEOGRAPHICAL SCOPE 13
• 2.3 YEARS CONSIDERED FOR THE STUDY 13
• 2.4 CURRENCY AND PRICING 13
• 2.5 DBMR TRIPOD DATA VALIDATION MODEL 14
• 2.6 MULTIVARIATE MODELLING 17
• 2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 18
• 2.8 DBMR MARKET POSITION GRID 19
• 2.9 MARKET APPLICATION COVERAGE GRID 20
• 2.10 SECONDARY SOURCES 21
• 2.11 ASSUMPTIONS 21

3 EXECUTIVE SUMMARY 22

4 PREMIUM INSIGHTS 24

• 4.1 PESTLE ANALYSIS 25
  • 4.1.1 POLITICAL FACTORS 25
  • 4.1.2 ECONOMIC FACTORS 26
  • 4.1.3 SOCIAL FACTORS 26
  • 4.1.4 TECHNOLOGICAL FACTORS 27
  • 4.1.5 LEGAL FACTORS 27
  • 4.1.6 ENVIRONMENTAL FACTORS 27
• 4.2 PORTER'S FIVE FORCES 28
  • 4.2.1 THREAT OF NEW ENTRANTS 28
  • 4.2.2 THREAT OF SUBSTITUTES 29
  • 4.2.3 CUSTOMER BARGAINING POWER 29
  • 4.2.4 SUPPLIER BARGAINING POWER 29
  • 4.2.5 INTERNAL COMPETITION (RIVALRY) 29

5 REGULATORY FRAMEWORK 30 

6 MARKET OVERVIEW 32

• 6.1 DRIVERS 34
  • 6.1.1 RISE IN THE CASES OF INFECTIOUS DISEASES 34
  • 6.1.2 TECHNOLOGICAL ADVANCEMENTS IN THE CLINICAL DIAGNOSTIC METHODS 34
  • 6.1.3 DEVELOPMENT IN DATABASE MANAGEMENT TOOLS AND WIDE ACCEPTANCE OF POINT-OF-CARE (POC) TESTING SOLUTIONS 35
  • 6.1.4 RISE IN DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS 35
• 6.2 RESTRAINTS 36
  • 6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS 36
  • 6.2.2 STRICT REGULATORY POLICIES 37
• 6.3 OPPORTUNITIES 37
  • 6.3.1 RISING POPULARITY OF DIGITAL PATHOLOGY PLATFORMS 37
  • 6.3.2 GROWTH IN AWARENESS AMONG POPULATION FOR PREVENTIVE HEALTH CHECK-UPS 38
• 6.4 CHALLENGE 39
  • 6.4.1 INACCURATE TEST OUTCOMES UNDERMINING PRECISION AND RELIABILITY 39

7 EUROPE 41

8 EUROPE CLINICAL LABORATORY SERVICES MARKET: COMPANY LANDSCAPE 42

• 8.1 COMPANY SHARE ANALYSIS: EUROPE 42

9 SWOT ANALYSIS 43

10 COMPANY PROFILES 44

• 10.1 ABBOTT 44
  • 10.1.1 COMPANY SNAPSHOT 44
  • 10.1.2 REVENUE ANALYSIS 44
  • 10.1.3 SERVICE PORTFOLIO 45
  • 10.1.4 RECENT DEVELOPMENTS 46
• 10.2 SONIC HEALTHCARE LIMITED 47
  • 10.2.1 COMPANY SNAPSHOT 47
  • 10.2.2 REVENUE ANALYSIS 47
  • 10.2.3 SERVICE PORTFOLIO 48
  • 10.2.4 RECENT DEVELOPMENT 48
• 10.3 SYNLAB INTERNATIONAL GMBH 49
  • 10.3.1 COMPANY SNAPSHOT 49
  • 10.3.2 REVENUE ANALYSIS 49
  • 10.3.3 SERVICE PORTFOLIO 50
  • 10.3.4 RECENT DEVELOPMENTS 50 
• 10.4 QUEST DIAGNOSTICS INCORPORATED 52
  • 10.4.1 COMPANY SNAPSHOT 52
  • 10.4.2 REVENUE ANALYSIS 52
  • 10.4.3 SERVICE PORTFOLIO 53
  • 10.4.4 RECENT DEVELOPMENT 53
• 10.5 SIEMENS HEALTHINEERS AG 54
  • 10.5.1 COMPANY SNAPSHOT 54
  • 10.5.2 REVENUE ANALYSIS 54
  • 10.5.3 SERVICE PORTFOLIO 55
  • 10.5.4 RECENT DEVELOPMENTS 55
• 10.6 ACM GLOBAL LABORATORIES 56
  • 10.6.1 COMPANY SNAPSHOT 56
  • 10.6.2 SERVICE PORTFOLIO 56
  • 10.6.3 RECENT DEVELOPMENT 56
• 10.7 AMEDES MEDICAL SERVICES GMBH 57
  • 10.7.1 COMPANY SNAPSHOT 57
  • 10.7.2 SERVICE PORTFOLIO 57
  • 10.7.3 RECENT DEVELOPMENT 57
• 10.8 CERBA HEALTHCARE 58
  • 10.8.1 COMPANY SNAPSHOT 58
  • 10.8.2 SERVICE PORTFOLIO 58
  • 10.8.3 RECENT DEVELOPMENT 58
• 10.9 CHARLES RIVER LABORATORIES 59
  • 10.9.1 COMPANY SNAPSHOT 59
  • 10.9.2 REVENUE ANALYSIS 59
  • 10.9.3 SERVICE PORTFOLIO 60
  • 10.9.4 RECENT DEVELOPMENT 60
• 10.10 EUROFINS SCIENTIFIC 61
  • 10.10.1 COMPANY SNAPSHOT 61
  • 10.10.2 REVENUE ANALYSIS 61
  • 10.10.3 SERVICE PORTFOLIO 62
  • 10.10.4 RECENT DEVELOPMENT 62
• 10.11 EXACT SCIENCES CORPORATION 63
  • 10.11.1 COMPANY SNAPSHOT 63
  • 10.11.2 REVENUE ANALYSIS 63
  • 10.11.3 SERVICE PORTFOLIO 64
  • 10.11.4 RECENT DEVELOPMENT 64 
• 10.12 H.U. GROUP HOLDINGS, INC. 65
  • 10.12.1 COMPANY SNAPSHOT 65
  • 10.12.2 REVENUE ANALYSIS 65
  • 10.12.3 SERVICE PORTFOLIO 66
  • 10.12.4 RECENT DEVELOPMENT 66
• 10.13 MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 67
  • 10.13.1 COMPANY SNAPSHOT 67
  • 10.13.2 SERVICE PORTFOLIO 67
  • 10.13.3 RECENT DEVELOPMENT 68
• 10.15 Q2 SOLUTIONS (A SUBSIDIARY OF IQVIA INC) 69
  • 10.15.1 COMPANY SNAPSHOT 69
  • 10.15.2 SERVICE PORTFOLIO 69
  • 10.15.3 RECENT DEVELOPMENTS 70
• 10.16 UNILABS 71
  • 10.16.1 COMPANY SNAPSHOT 71
  • 10.16.2 SERVICE PORTFOLIO 71
  • 10.16.3 RECENT DEVELOPMENTS 72

11 QUESTIONNAIRE 73

12 RELATED REPORTS 77

LIST OF FIGURES

• FIGURE 1 EUROPE CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION 12
• FIGURE 2 EUROPE CLINICAL LABORATORY SERVICES MARKET: DATA TRIANGULATION 14
• FIGURE 3 EUROPE CLINICAL LABORATORY SERVICES MARKET: DROC ANALYSIS 15
• FIGURE 4 EUROPE CLINICAL LABORATORY SERVICES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS 16
• FIGURE 5 EUROPE CLINICAL LABORATORY SERVICES MARKET: COMPANY RESEARCH ANALYSIS 16
• FIGURE 6 EUROPE CLINICAL LABORATORY SERVICES MARKET: INTERVIEW DEMOGRAPHICS 18
• FIGURE 7 EUROPE CLINICAL LABORATORY SERVICES MARKET: DBMR MARKET POSITION GRID 19
• FIGURE 8 EUROPE CLINICAL LABORATORY SERVICES MARKET APPLICATION COVERAGE GRID 20
• FIGURE 9 EUROPE CLINICAL LABORATORY SERVICES MARKET: SEGMENTATION 23
• FIGURE 10 RISING INFECTIOUS DISEASES WORLDWIDE AND RISING DEMAND FOR EARLY AND ACCURATE DISEASE DIAGNOSIS ARE EXPECTED TO DRIVE THE EUROPE CLINICAL LABORATORY SERVICES MARKET IN THE FORECAST PERIOD OF 2023 TO 2030 24
• FIGURE 11 THE ROUTINE TESTING SERVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CLINICAL LABORATORY SERVICES MARKET IN 2023 & 2030 24
• FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE CLINICAL LABORATORY SERVICES MARKET 33
• FIGURE 13 EUROPE CLINICAL LABORATORY SERVICES MARKET: SNAPSHOT (2022) 41
• FIGURE 14 EUROPE CLINICAL LABORATORY SERVICES MARKET: COMPANY SHARE 2022 (%) 42